Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00706823 · ClinicalTrials.gov registry record · NA
Comparison of I-gel to the Laryngeal Mask Airway
A NA study of Supraglottic Airway and Endotracheal Intubation, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT00706823: Completed NA study of Supraglottic Airway and Endotracheal Intubation, sponsored by The University of Texas Health Science Center, Houston.
NCT00706823 is a NA study of Supraglottic Airway and Endotracheal Intubation that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 50 participants, below the 12,247-participant average among 3 other Supraglottic Airway trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00706823, a NA study of Supraglottic Airway and Endotracheal Intubation, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion, position within the airway, drain tube patency and anatomic sealing properties during mechanical ventilation in non-obese anesthetized patients undergoing elective general surgery. The study device will be compared to the current standard in the industry, the LMA Unique.
Primary Outcome
The total time to intubation was measured from the beginning of supraglottic airway device (SGA) insertion to successful endotracheal tube intubation, verified by detection of CO2 on the capnogram (anesthesia machine).
Conditions Studied
Interventions
- DEVICE i-gel airway (Intersurgical Ltd., Wokingham, England)
- DEVICE Laryngeal Mask Airway-Unique
Study Locations (1)
Texas
- Memorial Hermann Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00706823 record still lists
NCT00706823 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 12,247-participant average among 3 other Supraglottic Airway trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Supraglottic Airway appearing as the primary indexed condition, and to 2 interventions - of which i-gel airway (Intersurgical Ltd., Wokingham, England) is the first listed.
NCT00706823 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00706823 about?
NCT00706823 is a clinical study titled "Comparison of I-gel to the Laryngeal Mask Airway". The purpose of this study is to evaluate a new disposable supra-glottic airway device, the i-gel airway (Intersurgical Ltd., Wokingham, England). We propose to test its ease of insertion, position within the airway, drain tube patency and anatomic sealing properties during mechanical ventilation in ...
What is the current status of trial NCT00706823?
This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2008-02. Estimated completion is 2008-08.
What conditions does trial NCT00706823 study?
This clinical trial studies the following conditions: Supraglottic Airway, Endotracheal Intubation.
What interventions are being tested in trial NCT00706823?
The interventions under investigation include: i-gel airway (Intersurgical Ltd., Wokingham, England) (DEVICE), Laryngeal Mask Airway-Unique (DEVICE).
Who is sponsoring clinical trial NCT00706823?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00706823 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Supraglottic Airway
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia